Table 1.
Quality assessment of studies based on the EPHPP criteria (studies sorted by disease alphabetically, SB: Selection Bias, SD: Study Design, CF: Confounders, BL: Blinding, DC: Data Collection, WD: Withdrawals and Dropouts, GR: EPHPP Global Rating, W: Weak, M: Moderate, S: Strong).
| Authors | SB | SD | CF | BL | DC | WD | GR |
|---|---|---|---|---|---|---|---|
| Ellis et al., 2019 [32] | M | S | M | M | M | S | S |
| Ginis et al., 2016 [33] | W | S | W | W | S | S | W |
| Landers et al., 2020 [34] | W | M | W | M | M | W | W |
| Golan et al., 2020 [35] | S | S | M | M | M | S | S |
| Nasseri et al., 2020 [36] | M | S | M | M | S | S | S |
| Pedullà et al., 2016 [37] | M | S | S | S | S | S | S |
| Van Geel et al., 2020 [38] | M | M | W | M | S | M | M |
| Burgos et al., 2020 [39] | M | S | W | M | S | W | W |
| Chae et al., 2020 [40] | M | M | S | M | M | M | S |
| Choi et al., 2016 [41] | W | S | W | S | S | S | W |
| Chung et al., 2020 [42] | M | S | S | S | W | S | M |
| Grau-Pellicer et al., 2020 [43] | W | S | S | W | S | S | W |
| Ifejika et al., 2020 [44] | M | S | S | S | S | M | S |
| Kang et al., 2019 [45] | M | S | S | M | S | M | S |
| Langan et al., 2020 [46] | W | M | W | M | S | S | W |
| Paul et al., 2016 [47] | M | S | W | W | S | S | W |
| Requena et al., 2019 [48] | W | M | M | M | M | W | W |
| Sarfo et al., 2018 [49] | M | M | W | M | S | S | M |
| Sawant et al., 2020 [50] | W | W | W | M | S | S | W |
| Verna et al., 2020 [51] | M | S | S | M | S | S | S |
| Xu et al., 2021 [52] | W | W | S | M | M | W | W |